Clinical and Ultrasonographic Predictors of IUD Related Complications

Clinical and Ultrasonographic Predictors of IUD Related Complications: A Prospective Cohort Study

• All patients fulfilling the selection criteria undergo complete clinical examination and detailed medical history obtained. Each patient had a Case Record Form (CRF) recording participants' name. number, previous deliveries and abortions, age, height, weight, BMI, LMP, past medical and surgical history and contraceptive history.
• All participants will be subjected to transvaginal ultrasound to measure uterine size, endometrial and myometrial thickness, uterine position, cervical length, cervical diameter and for detection of any contraindications for IUD insertion.

Power Doppler Energy (PDE) measurement for subendometrial microvascularization will be done and categorized as women with minor subendometrial vascularization (Classifications I and II) and major subendometrial vascularization (Classifications III, IV and V)

Study Overview

• Status: Recruiting
• Conditions: IUCD Complication
• Intervention / Treatment: Device: IUD insertion

Detailed Description

All patients fulfilling the selection criteria undergo complete clinical examination and detailed medical history obtained. Each patient had a Case Record Form (CRF) recording participants' name. number, previous deliveries and abortions, age, height, weight, BMI, LMP, past medical and surgical history and contraceptive history.

- All participants will be subjected to transvaginal ultrasound to measure uterine size, endometrial and myometrial thickness, uterine position, cervical length, cervical diameter and for detection of any contraindications for IUD insertion.

Power Doppler Energy (PDE) measurement for subendometrial microvascularization will be done and categorized as women with minor subendometrial vascularization (Classifications I and II) and major subendometrial vascularization (Classifications III, IV and V)

Only clinicians with proven proficiency in IUD insertion will be allowed to perform insertions.

• Perform a bimanual examination to determine the size, shape, and position of the uterus.
• Insert a warm, moistened speculum.
• Cleanse the cervix with an antiseptic solution.
• Open the sterile insertion instruments without touching the inside of the packet and place within easy reach.
• Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix. Close gently to the first notch. Having the woman to cough while the tenaculum is being attached can ease the pinch.
• Apply gentle traction with the tenaculum to straighten the canal.
• Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed, note the depth of the uterine cavity. The woman can expect to feel cramping as the sound is inserted and withdrawn.
• Open the IUD pack without touching its contents.
• Put on sterile gloves.
• Load the IUD and insert it into the uterine cavity according to the manufacturer instructions. As the IUD is inserted through the cervix into the uterus, the patient may have pain and cramping similar to strong menstrual cramps.
• Gently remove the tenaculum. Tamponade any bleeding from the tenaculum site until it is resolved.
• Trim the strings of the IUD to 3-4 cm in length and note the string length. Avoid cutting the strings too short. If the client or her partner becomes aware of the threads, they may be cut shorter in length at the follow-up visit.
• Remove the speculum and assess the woman.

• Pain score will be assessed using Visual Analogue Scale:

  1. Anticipated pain or current pain before the intervention.
  2. Immediately after speculum insertion.
  3. Immediately after tenaculum placement.
  4. Immediately after uterine sounding.
  5. During or immediately after IUD insertion.

  6. Five minutes after the procedure

     • Follow up at 3 and 6 months to assess women satisfaction with the method, menstrual pattern, symptoms of vaginal/pelvic infection Abdominal pain/tenderness Dyspareunia (woman/partner) Cramping or pregnancy.
     • Vaginal examination to assess any infections or abnormalities and repeat ultrasound examination to assess the position of the IUD

• Study Type: Interventional
• Enrollment (Estimated): 200
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ahmed Maged; Phone Number: +201005227404; Email: ahmedmaged@cu.edu.eg
• Study Contact Backup: Name: Ahmed chamel; Phone Number: +20 110 066 2255; Email: ahmed-chamel@hotmail.com

Study Locations

• Egypt
  • Cairo, Egypt, 12111
    • Recruiting
    • Kasr Alainy Medical School
    • Contact: Ahmed Maged, MD; Phone Number: 01005227404; Email: prof.ahmedmaged@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Age 20 -41 years
• BMI 18-25 kg/m2
• Women with any parity seeking contraception and choosing IUD as their preferred method after proper and thorough counseling
• Regularly menstruating women (duration of menstruation 3-7 days and length of cycle 22- 35 days).
• Not using any hormonal therapy or anticoagulation

Exclusion Criteria:

• Cervical abnormalities.
• Pregnancy or suspicion of pregnancy
• Congenital or acquired uterine anomalies which distort the uterine cavity (fibroids, endometrial polyps, cervical stenosis, bicornuate uterus, hypoplastic uterus < 6 cm)
• Acute PID or a history of PID within the past 3 months
• Postpartum or post-abortion endometritis within the past 3 months
• Current STI or within the past 3 months (including cervicitis)
• Cervical cancer
• Endometrial cancer
• Malignant gestational trophoblastic disease
• Undiagnosed vaginal bleeding
• Hypersensitivity to any component in the IUD (copper)
• Less than 6 weeks postpartum.
• Neurological or psychological conditions that may affect pain sensation

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: IUD insertion; IUD insertion in women needing contraception

Device: IUD insertion; Perform a bimanual examination; Insert a warm, moistened speculum.; Cleanse the cervix with an antiseptic solution.; Open the sterile insertion instruments without touching; Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix.; Apply gentle traction with the tenaculum to straighten the canal.; Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed; Open the IUD pack without touching its contents.; Put on sterile gloves.; Load the IUD and insert it into the uterine cavity according to the manufacturer instructions.; Gently remove the tenaculum.; Trim the strings of the IUD to 3-4 cm in length; Remove the speculum and assess the woman.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Failed IUD insertion	failure of IUD insertion	9 months

Collaborators and Investigators

• Sponsor: Cairo University
• Investigators: Principal Investigator: Ahmed Maged, Cairo university

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2025
• Primary Completion (Estimated): February 1, 2026
• Study Completion (Estimated): February 1, 2026

Study Registration Dates

• First Submitted: January 21, 2025
• First Submitted That Met QC Criteria: January 28, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: March 17, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: N 362

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No